Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Abstract: Learning over time for machine learning (ML) models is emerging as a new field, often called continual learning or lifelong Machine learning (LML). Today, deep learning and neural networks ...